Skip to main content
Sartorius AG logo

Sartorius AG — Investor Relations & Filings

Ticker · SRT3 ISIN · DE0007165607 LEI · 529900EQV2DY4FOAMU38 F Manufacturing
Filings indexed 392 across all filing types
Latest filing 2024-02-06 Transaction in Own Shar…
Country DE Germany
Listing F SRT3

About Sartorius AG

https://www.sartorius.com/en

Sartorius is a leading international partner for the biopharmaceutical industry and life science research. The company provides a comprehensive portfolio of products and services that support the entire drug development and manufacturing process, from initial discovery to production. Key offerings include advanced solutions for filtration, fermentation, fluid management, cell analysis, and process analytics. The laboratory products division supplies essential equipment such as balances, pipettes, and water purification systems. Sartorius focuses on simplifying complex scientific processes to help customers translate discoveries into effective medicines more quickly and efficiently.

Recent filings

Filing Released Lang Actions
SARTORIUS AG: Sartorius launches placement of up to 200 million euros of treasury preference shares through accelerated bookbuilding
Transaction in Own Shares Classification · 98% confidence The document is an 'Ad-hoc' announcement dated February 6, 2024, disclosing 'inside information' under MAR (Regulation (EU) No 596/2014). The core subject is the launch of a placement of treasury preference shares by Sartorius AG through an accelerated bookbuilding process, explicitly mentioning the exclusion of existing shareholders' subscription rights. This action directly relates to the company managing its own shares for financing purposes. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers share repurchase/issuance activities. Although it involves capital structure, the specific action described is the placement (sale) of treasury shares, making POS the most precise fit over CAP (Capital/Financing Update).
2024-02-06 English
Sartorius expects profitable growth in 2024; double-digit annual sales revenue growth projected through to 2028 (news with additional features)
Earnings Release Classification · 100% confidence The document is titled with 'Sartorius expects profitable growth in 2024; double-digit annual sales revenue growth projected through to 2028 (news with additional features)' and contains preliminary financial results for 2023, guidance for 2024, and a medium-term outlook to 2028. It uses keywords like 'Preliminary 2023 results', 'sales revenue', 'EBITDA margin', and 'Guidance for fiscal year 2024'. This structure strongly indicates an initial announcement of periodic financial results, focusing on key highlights and forward-looking statements, rather than the comprehensive filing (like a 10-K or IR). Therefore, it fits the definition of an Earnings Release (ER). The document length is substantial (23,659 chars), suggesting it is more than just a brief announcement, but the content is focused on summarizing preliminary results and providing guidance, which is the core function of an ER. FY 2023
2024-01-26 English
Sartorius AG: Dr. Rene Faber, Transfer of 1525 preference shares as a share-based remuneration component in fulfillment of the corresponding grant from December 2023
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a 'Notification and public disclosure of transactions by persons discharging managerial responsibilities'. Section 4 details a 'Transfer of 1525 preference shares as a share-based remuneration component' by Dr. René Fáber, a Member of the managing body. This content directly matches the definition for Director's Dealing (DIRS). The document length is short, but the content is the primary disclosure itself, not an announcement of a report.
2024-01-02 English
Sartorius AG: Dr. Rene Faber, Transfer of 1923 ordinary shares as a share-based remuneration component in fulfillment of the corresponding grant from December 2023
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and details a transaction involving a member of the managing body (Dr. René Fáber) transferring shares as a remuneration component. This directly corresponds to the definition of Director's Dealing, which is classified under the code DIRS.
2024-01-02 English
Sartorius AG: Dr. Alexandra Gatzemeyer, Transfer of 1186 preference shares as a share-based remuneration component in fulfillment of the corresponding grant from December 2023
Director's Dealing Classification · 100% confidence The document explicitly states 'Directors’ Dealings' in the header and details a 'Transfer of 1186 preference shares as a share-based remuneration component' by a member of the managing body (Dr. Alexandra Gatzemeyer). This directly corresponds to the definition of Director's Dealing, which is classified under the code DIRS (Report of personal share transactions by company directors and executives (insider trades)). The document structure is typical of a regulatory disclosure regarding insider transactions.
2024-01-02 English
Sartorius AG: Dr. Alexandra Gatzemeyer, Transfer of 1496 ordinary shares as a share-based remuneration component in fulfillment of the corresponding grant from December 2023
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details a transaction involving Dr. Alexandra Gatzemeyer, a Member of the managing body, transferring shares as a remuneration component. This perfectly matches the definition for Director's Dealing (DIRS). The document length is short (2406 chars), but the content is the primary disclosure itself, not an announcement of a report, thus ruling out RPA/RNS based on the 'Menu vs Meal' rule contextually applied to the specific filing type.
2024-01-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.